REQUEST A DEMO
Total
USD $0.00
Search more companies

TRIZLEX BIOPHARMA OU (Estonia)

Main Activities: Administrative Management and General Management Consulting Services
Full name: TRIZLEX BIOPHARMA OU Profile Updated: July 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

TRIZLEX BIOPHARMA OU is an enterprise based in Estonia. Its main office is in Saue. The enterprise operates in the Administrative Management and General Management Consulting Services industry. The company was established on February 10, 2006. The latest financial highlights indicate a net sales revenue increase of 30.51% in 2025. A growth of 50.03% was recorded in its total assets. In, 2025, the company’s net profit margin increased by 27.45%.

Headquarters
Pilliroo tn 81 Laagri alevik
Saue; Harju county; Postal Code: 76401

Contact Details: Purchase the TRIZLEX BIOPHARMA OU report to view the information.

Basic Information
Registered Capital:
Purchase the TRIZLEX BIOPHARMA OU report to view the information.
Financial Auditors:
Purchase the TRIZLEX BIOPHARMA OU report to view the information.
Incorporation Date:
February 10, 2006
Key Executives
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after TRIZLEX BIOPHARMA OU report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
30.51%
Total Operating Revenue
30.51%
Operating Profit
96.77%
Net Profit/Loss for the Period
114.95%
Total Assets
50.03%
Total Equity
53.96%
Operating Profit Margin
21.54%
Net Profit Margin
27.45%
Return on Equity (ROE)
18.6%
Cash Ratio
-32.86%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?